This "test" is a study that has been done in Canada for dysplasia patients. As we know, dysplasia is NOT cancer and most often does NOT turn into anyt cancer or anything serious. This product in Canada is focusing on cost effectiveness of being able to predict which dysplasia patients have a higher risk of their dysplasia turning into OC. This product supposedly is able to predict up to 5 years out if a patients dysplasia could change and become cancerous. According to a highly respected physician advisor to OCF for over a decade, who has worked over 20 years researching molecular markers, this product still has a long road to go before it will pass US FDA approval. This is not something OCF would endorse unless there were major changes and it lived up to actually do the things its claimed to do.

We can all hope things like this will be possible for ALL patients, everywhere. By finding OC earlier would not only reduce how traumatic OC treatments affect patients but also dramatically lower the morbidity of those with OC. Imagine going in to your family doctor for a yearly check up and being able to know if you will face going thru cancer within the next year. Finding OC earlier when its small and easier to treat would be so much easier on patients. One day...

SCC 6/15/07 L chk & by L molar both Stag I, age44
2x cispltn-35 IMRT end 9/27/07
-65 lbs in 2 mo, no caregvr
Clear PET 1/08
4/4/08 recur L chk Stag I
surg 4/16/08 clr marg
215 HBO dives
3/09 teeth out, trismus
7/2/09 recur, Stg IV
8/24/09 trach, ND, mandiblctmy
3wks medicly inducd coma
2 mo xtended hospital stay, ICU & burn unit
PICC line IV antibx 8 mo
10/4/10, 2/14/11 reconst surg
OC 3x in 3 years
very happy to be alive smile